β2‐Adrenergic Receptor Gene Affects the Heart Rate Response of β‐Blockers: Evidence From 3 Clinical Studies.

Autor: Shahin, Mohamed H., Rouby, Nihal El, Conrado, Daniela J., Gonzalez, Daniel, Gong, Yan, Lobmeyer, Maximilian T., Beitelshees, Amber L., Boerwinkle, Eric, Gums, John G., Chapman, Arlene, Turner, Stephen T., Pepine, Carl J., Cooper‐DeHoff, Rhonda M., Johnson, Julie A.

Publikováno v: Journal of Clinical Pharmacology; Nov2019, Vol. 59 Issue 11, p1462-1470, 9p

PTPRD gene associated with blood pressure response to atenolol and resistant hypertension.

Autor: Yan Gong, McDonough, Caitrin W., Beitelshees, Amber L., Rouby, Nihal El, Hiltunen, Timo P., O'Connell, Jeffrey R., Padmanabhan, Sandosh, Langaee, Taimour Y., Hall, Karen, Schmidt, Siegfried O. F., Curry Jr, Robert W., Gums, John G., Donner, Kati M., Kontula, Kimmo K., Bailey, Kent R., Boerwinkle, Eric, Takahashi, Atsushi, Tanaka, Toshihiro, Kubo, Michiaki, Chapman, Arlene B.

Publikováno v: Journal of Hypertension; Nov2015, Vol. 33 Issue 11, p2278-2285, 8p

β 2 -Adrenergic Receptor Gene Affects the Heart Rate Response of β-Blockers: Evidence From 3 Clinical Studies.

Autor: Shahin MH; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, FL, USA., Rouby NE; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, FL, USA., Conrado DJ; Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL, USA., Gonzalez D; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA., Gong Y; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, FL, USA., Lobmeyer MT; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, FL, USA., Beitelshees AL; Department of Medicine, University of Maryland, Baltimore, MD, USA., Boerwinkle E; Human Genetics Center and Institute of Molecular Medicine, University of Texas Health Science Center, Houston, TX, USA., Gums JG; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, FL, USA., Chapman A; Department of Medicine, The University of Chicago, Chicago, IL, USA., Turner ST; Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Pepine CJ; Division of Cardiovascular Medicine, Department of Medicine, University of Florida, College of Medicine, Gainesville, FL, USA., Cooper-DeHoff RM; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, FL, USA.; Division of Cardiovascular Medicine, Department of Medicine, University of Florida, College of Medicine, Gainesville, FL, USA., Johnson JA; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, FL, USA.; Division of Cardiovascular Medicine, Department of Medicine, University of Florida, College of Medicine, Gainesville, FL, USA.

Publikováno v: Journal of clinical pharmacology [J Clin Pharmacol] 2019 Nov; Vol. 59 (11), pp. 1462-1470. Date of Electronic Publication: 2019 May 14.